CO-DIAGNOSTICS INC (CODX) Fundamental Analysis & Valuation

NASDAQ:CODX • US1897632048

Current stock price

2.5 USD
-0.3 (-10.71%)
At close:
2.5 USD
0 (0%)
After Hours:

This CODX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. CODX Profitability Analysis

1.1 Basic Checks

  • In the past year CODX has reported negative net income.
  • CODX had a negative operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: CODX reported negative net income in multiple years.
  • In multiple years CODX reported negative operating cash flow during the last 5 years.
CODX Yearly Net Income VS EBIT VS OCF VS FCFCODX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M

1.2 Ratios

  • CODX's Return On Assets of -71.93% is on the low side compared to the rest of the industry. CODX is outperformed by 74.46% of its industry peers.
  • CODX's Return On Equity of -80.80% is in line compared to the rest of the industry. CODX outperforms 40.22% of its industry peers.
Industry RankSector Rank
ROA -71.93%
ROE -80.8%
ROIC N/A
ROA(3y)-35.82%
ROA(5y)-4.97%
ROE(3y)-40.94%
ROE(5y)-6.37%
ROIC(3y)N/A
ROIC(5y)N/A
CODX Yearly ROA, ROE, ROICCODX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400 600

1.3 Margins

  • With a Gross Margin value of 34.04%, CODX is not doing good in the industry: 74.46% of the companies in the same industry are doing better.
  • In the last couple of years the Gross Margin of CODX has grown nicely.
  • CODX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 34.04%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.47%
GM growth 5Y9.36%
CODX Yearly Profit, Operating, Gross MarginsCODX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20K -40K -60K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. CODX Health Analysis

2.1 Basic Checks

  • CODX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for CODX has been increased compared to 1 year ago.
  • Compared to 5 years ago, CODX has more shares outstanding
  • CODX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CODX Yearly Shares OutstandingCODX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
CODX Yearly Total Debt VS Total AssetsCODX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

  • CODX has an Altman-Z score of 16.80. This indicates that CODX is financially healthy and has little risk of bankruptcy at the moment.
  • CODX has a better Altman-Z score (16.80) than 95.11% of its industry peers.
  • There is no outstanding debt for CODX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 16.8
ROIC/WACCN/A
WACC10.05%
CODX Yearly LT Debt VS Equity VS FCFCODX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

  • A Current Ratio of 3.81 indicates that CODX has no problem at all paying its short term obligations.
  • The Current ratio of CODX (3.81) is better than 64.67% of its industry peers.
  • A Quick Ratio of 3.51 indicates that CODX has no problem at all paying its short term obligations.
  • CODX has a Quick ratio of 3.51. This is in the better half of the industry: CODX outperforms 68.48% of its industry peers.
Industry RankSector Rank
Current Ratio 3.81
Quick Ratio 3.51
CODX Yearly Current Assets VS Current LiabilitesCODX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. CODX Growth Analysis

3.1 Past

  • CODX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1416.54%.
  • The Revenue for CODX has decreased by -93.06% in the past year. This is quite bad
  • CODX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 79.52% yearly.
EPS 1Y (TTM)-1416.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1400%
Revenue 1Y (TTM)-93.06%
Revenue growth 3Y-65.8%
Revenue growth 5Y79.52%
Sales Q2Q%-77.38%

3.2 Future

  • Based on estimates for the next years, CODX will show a very strong growth in Earnings Per Share. The EPS will grow by 51.41% on average per year.
  • The Revenue is expected to grow by 101.21% on average over the next years. This is a very strong growth
EPS Next Y-1795.58%
EPS Next 2Y-231.17%
EPS Next 3Y-121.26%
EPS Next 5Y51.41%
Revenue Next Year-88.3%
Revenue Next 2Y-62.71%
Revenue Next 3Y60.7%
Revenue Next 5Y101.21%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CODX Yearly Revenue VS EstimatesCODX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 100M 200M 300M
CODX Yearly EPS VS EstimatesCODX Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 20 -20

More info and screens

Find the best growth stocksShow best growing peers

0

4. CODX Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for CODX. In the last year negative earnings were reported.
  • Also next year CODX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CODX Price Earnings VS Forward Price EarningsCODX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CODX Per share dataCODX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -5 -10 -15

4.3 Compensation for Growth

  • A cheap valuation may be justified as CODX's earnings are expected to decrease with -121.26% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-231.17%
EPS Next 3Y-121.26%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CODX Dividend Analysis

5.1 Amount

  • No dividends for CODX!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CODX Fundamentals: All Metrics, Ratios and Statistics

CO-DIAGNOSTICS INC

NASDAQ:CODX (3/16/2026, 8:16:22 PM)

After market: 2.5 0 (0%)

2.5

-0.3 (-10.71%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-13
Earnings (Next)03-25
Inst Owners18.52%
Inst Owner Change-1.33%
Ins Owners5.87%
Ins Owner Change5.92%
Market Cap152.22M
Revenue(TTM)507.90K
Net Income(TTM)-32.18M
Analysts80
Price Target38.25 (1430%)
Short Float %0.01%
Short Ratio0
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)32.8%
Min EPS beat(2)1.96%
Max EPS beat(2)63.63%
EPS beat(4)3
Avg EPS beat(4)22.62%
Min EPS beat(4)-3.81%
Max EPS beat(4)63.63%
EPS beat(8)5
Avg EPS beat(8)-4.35%
EPS beat(12)7
Avg EPS beat(12)-30.05%
EPS beat(16)10
Avg EPS beat(16)-21.09%
Revenue beat(2)1
Avg Revenue beat(2)0.65%
Min Revenue beat(2)-5.23%
Max Revenue beat(2)6.54%
Revenue beat(4)1
Avg Revenue beat(4)-36.65%
Min Revenue beat(4)-86.85%
Max Revenue beat(4)6.54%
Revenue beat(8)3
Avg Revenue beat(8)53.36%
Revenue beat(12)4
Avg Revenue beat(12)112.38%
Revenue beat(16)5
Avg Revenue beat(16)77.24%
PT rev (1m)0%
PT rev (3m)2900%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-2900%
EPS NY rev (1m)0%
EPS NY rev (3m)-2900%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 299.71
P/FCF N/A
P/OCF N/A
P/B 3.82
P/tB 11.09
EV/EBITDA N/A
EPS(TTM)-19.26
EYN/A
EPS(NY)-12.39
Fwd EYN/A
FCF(TTM)-0.52
FCFYN/A
OCF(TTM)-0.51
OCFYN/A
SpS0.01
BVpS0.65
TBVpS0.23
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -71.93%
ROE -80.8%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 34.04%
FCFM N/A
ROA(3y)-35.82%
ROA(5y)-4.97%
ROE(3y)-40.94%
ROE(5y)-6.37%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.47%
GM growth 5Y9.36%
F-Score2
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 53.59%
Cap/Sales 126.23%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.81
Quick Ratio 3.51
Altman-Z 16.8
F-Score2
WACC10.05%
ROIC/WACCN/A
Cap/Depr(3y)92.34%
Cap/Depr(5y)204.81%
Cap/Sales(3y)14.45%
Cap/Sales(5y)9.01%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1416.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1400%
EPS Next Y-1795.58%
EPS Next 2Y-231.17%
EPS Next 3Y-121.26%
EPS Next 5Y51.41%
Revenue 1Y (TTM)-93.06%
Revenue growth 3Y-65.8%
Revenue growth 5Y79.52%
Sales Q2Q%-77.38%
Revenue Next Year-88.3%
Revenue Next 2Y-62.71%
Revenue Next 3Y60.7%
Revenue Next 5Y101.21%
EBIT growth 1Y11.17%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-41.31%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-46.26%
OCF growth 3YN/A
OCF growth 5YN/A

CO-DIAGNOSTICS INC / CODX Fundamental Analysis FAQ

What is the ChartMill fundamental rating of CO-DIAGNOSTICS INC (CODX) stock?

ChartMill assigns a fundamental rating of 4 / 10 to CODX.


What is the valuation status of CO-DIAGNOSTICS INC (CODX) stock?

ChartMill assigns a valuation rating of 0 / 10 to CO-DIAGNOSTICS INC (CODX). This can be considered as Overvalued.


What is the profitability of CODX stock?

CO-DIAGNOSTICS INC (CODX) has a profitability rating of 1 / 10.


How financially healthy is CO-DIAGNOSTICS INC?

The financial health rating of CO-DIAGNOSTICS INC (CODX) is 8 / 10.